673 — China Health Share Price
Last trade - 00:00- HK$416.73m
- HK$425.35m
- HK$76.41m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.53 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.6 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -9.79% | ||
| Return on Equity | -44.43% | ||
| Operating Margin | -30.7% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 32.18 | 45.16 | 87.89 | 107.03 | 76.41 | n/a | n/a | 25.81% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
China Health Group Limited is a Hong Kong-based investment holding company principally engaged in the trading of medical equipment and consumables. The Company mainly operates its business through four segments. The Trading of Medical Equipment And Consumables segment engages in the medical equipment trading business and trading of medical consumables business. The Hospital Management Service segment is engaged in the operation of Shuangluan Hospital, Anping Bo’ai Hospital, Red Cross Hospital of Luanping County and the Hong Fu Eldercare and Nursing Home of Luanping County, among others. The Property Investment segment is engaged in acquisition of properties of Anping Bo’ai Hospital and generate rental income. The Business Factoring segment operates business factoring business for hospitals.
Directors
- Fan Zhang CHM (53)
- Ho Chung CEO (51)
- Jiuru Ding CFO (56)
- Zhong Yuan Li EDR (59)
- Kai Zhao EDR (37)
- Siu Hung Tsui SEC (45)
- Lianhai Huang NED (37)
- Jingming Wang NED (64)
- Yong Xing NED (46)
- Yanhua Du NID (51)
- Xuejun Jiang NID (49)
- Liangquan Lai NID (42)
- Hua Zhao NID (62)
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- November 16th, 2000
- Public Since
- October 14th, 1996
- No. of Employees
- 133
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 478,994,763
- Address
- Unit 801,8/F.,China Insurance Group Bldg
- Web
- http://www.ch-groups.com/
- Phone
- +852 null21161990
- Auditors
- Elite Partners CPA Limited
Upcoming Events for 673
Similar to 673
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:05 UTC, shares in China Health are trading at HK$0.87. This share price information is delayed by 15 minutes.
Shares in China Health last closed at HK$0.87 and the price had moved by -28.1% over the past 365 days. In terms of relative price strength the China Health share price has underperformed the FTSE Developed Asia Pacific Index by -24.95% over the past year.
There is no consensus recommendation for this security.
China Health does not currently pay a dividend.
China Health does not currently pay a dividend.
China Health does not currently pay a dividend.
To buy shares in China Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.87, shares in China Health had a market capitalisation of HK$416.73m.
Here are the trading details for China Health:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 673
Based on an overall assessment of its quality, value and momentum China Health is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like China Health. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -34.08%.
As of the last closing price of HK$0.87, shares in China Health were trading -17.12% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The China Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.87.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
China Health's management team is headed by:
- Fan Zhang - CHM
- Ho Chung - CEO
- Jiuru Ding - CFO
- Zhong Yuan Li - EDR
- Kai Zhao - EDR
- Siu Hung Tsui - SEC
- Lianhai Huang - NED
- Jingming Wang - NED
- Yong Xing - NED
- Yanhua Du - NID
- Xuejun Jiang - NID
- Liangquan Lai - NID
- Hua Zhao - NID